NSC-139021 | B2199

NSC-139021 (ERGi-USU) is a highly selective inhibitor for the growth of ERG-positive cancer cells with IC₅₀s ranging from 30 to 400 nM. NSC-139021 displays minimal effect on normal prostate or endothelial cells or ERG-negative tumor cell lines.

NSC-139021 (ERGi-USU) is a highly selective inhibitor for the growth of ERG-positive cancer cells with IC₅₀s ranging from 30 to 400 nM. NSC-139021 displays minimal effect on normal prostate or endothelial cells or ERG-negative tumor cell lines.

B2199 | NSC-139021 DataSheet

Alternate Name/Synonyms: 1-(2-Thiazolylazo)-2-naphthol; 1-(2-Thiazoylazo)-2-naphthol; 1147-56-4; MLS000738280; 2-Naphthol, 1-(2-thiazolylazo); TAN

Appearance: Dark orange to red solid

Formulation: N/A

CAS Number: 1147-56-4

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₃H₉N₃OS

Molecular Weight: 255.3

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A highly selective inhibitor for the growth of ERG-positive cancer cells

MDL Number: MFCD00021611

PubChem CID: 6308684

SMILES: C1=CC=C2C(=C1)C=CC(=O)C2=NNC3=NC=CS3

InChi: InChI=1S/C13H9N3OS/c17-11-6-5-9-3-1-2-4-10(9)12(11)15-16-13-14-7-8-18-13/h1-8H,(H,14,16)/b15-12-

InChi Key: GCBAKGGJQPMJLL-QINSGFPZSA-N